<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03331300099881</udiDi>
    <basicUdiDi>0022600LLVM-MULTIUSEXB</basicUdiDi>
    <tradeName>Replens® App. Reutilisable 35G FR</tradeName>
    <deviceName>Long Lasting Vaginal Moisturizer - Multi-Use (LLVM-MU)</deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03331300099881</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:15:38.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>03331300096323</udiDi>
    <basicUdiDi>0022600LLVM-SINGLEUSEQN</basicUdiDi>
    <tradeName>Replens® LLVM FR X4 Applicateurs</tradeName>
    <deviceName>Long Lasting Vaginal Moisturizer - Single Use (LLVM-SU)</deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03331300096323</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:15:35.052Z</lastUpdated>
  </row>
  <row>
    <udiDi>03331300098259</udiDi>
    <basicUdiDi>0022600OEG-SINGLEUSEX7</basicUdiDi>
    <tradeName>Replens Vaginal Odour Treatment</tradeName>
    <deviceName>Odor Eliminating Gel</deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03331300098259</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:15:33.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.4C4</udiDi>
    <basicUdiDi>B-FT.CE.116.4C4</basicUdiDi>
    <tradeName>Gynè Ovuli</tradeName>
    <deviceName>Gynè Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.4</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:03:35.106Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.116.3.CAMP*RC</udiDi>
    <basicUdiDi>B-FT.CE.116.3.CAMP*RC</basicUdiDi>
    <tradeName>Eutylia Elle Ovuli</tradeName>
    <deviceName>Eutylia Elle Ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.116.3.CAMP*</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-17T02:03:33.490Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-707301PL</udiDi>
    <basicUdiDi>B-707301PL</basicUdiDi>
    <tradeName>Lucovital  Vagimed Plus 10 ovules</tradeName>
    <deviceName>Vaginal Dryness Ovules</deviceName>
    <manufacturerName>PK Benelux BV</manufacturerName>
    <manufacturerSrn>NL-MF-000006672</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>707301</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T01:29:13.686Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-590387490GHXXLT</udiDi>
    <basicUdiDi>B-590387490GHXXLT</basicUdiDi>
    <tradeName>FLORAKCID  HA 10 mg</tradeName>
    <deviceName>Vaginal globules with hyaluronic acid</deviceName>
    <manufacturerName>"Biofaktor" Sp. z o. o.</manufacturerName>
    <manufacturerSrn>PL-MF-000027226</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GH</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-17T00:04:16.257Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-590387490GHANSH7</udiDi>
    <basicUdiDi>B-590387490GHANSH7</basicUdiDi>
    <tradeName>Hyalotim</tradeName>
    <deviceName>Vaginal globules with hyaluronic acid and lactic acid</deviceName>
    <manufacturerName>"Biofaktor" Sp. z o. o.</manufacturerName>
    <manufacturerSrn>PL-MF-000027226</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GHA</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-17T00:04:12.735Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-590387490GAXHJQ</udiDi>
    <basicUdiDi>B-590387490GAXHJQ</basicUdiDi>
    <tradeName>Intivag</tradeName>
    <deviceName>Vaginal globules with lactic acid</deviceName>
    <manufacturerName>"Biofaktor" Sp. z o. o.</manufacturerName>
    <manufacturerSrn>PL-MF-000027226</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GA</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-17T00:04:11.786Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-5902020845300UZ</udiDi>
    <basicUdiDi>B-5902020845300UZ</basicUdiDi>
    <tradeName>Iladian direct plus/Lafemidia PL PT</tradeName>
    <deviceName>Iladian Direct Plus/Lafemidia</deviceName>
    <manufacturerName>Aflofarm Farmacja Polska Sp. z o.o.</manufacturerName>
    <manufacturerSrn>PL-MF-000001809</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>many</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:57:53.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-507126NY</udiDi>
    <basicUdiDi>B-507126NY</basicUdiDi>
    <tradeName>Balance Activ BV Treatment Gel</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Rolf Kullgren AB</manufacturerName>
    <manufacturerSrn>SE-MF-000021108</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>507126</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:35:03.027Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-50475</udiDi>
    <basicUdiDi>B-50475</basicUdiDi>
    <tradeName>Membrasin Vaginal Vitality Cream</tradeName>
    <deviceName>Membrasin Vaginal Vitality Cream</deviceName>
    <manufacturerName>Aromtech Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000016176</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GMN 642061873504AYR</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:18:13.004Z</lastUpdated>
  </row>
  <row>
    <udiDi>05010724535806</udiDi>
    <basicUdiDi>0022600OEG-SINGLEUSEX7</basicUdiDi>
    <tradeName>ReplensMD BV Relief Vaginal Gel</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05010724535806</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:48:44.061Z</lastUpdated>
  </row>
  <row>
    <udiDi>05010724529270</udiDi>
    <basicUdiDi>0022600LLVM-SINGLEUSEQN</basicUdiDi>
    <tradeName>Replens® Filled Applicators X6 UK 2024</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05010724529270</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:48:38.949Z</lastUpdated>
  </row>
  <row>
    <udiDi>05010724529287</udiDi>
    <basicUdiDi>0022600LLVM-SINGLEUSEQN</basicUdiDi>
    <tradeName>Replens® Filled Applicators X12 UK</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05010724529287</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:47:41.220Z</lastUpdated>
  </row>
  <row>
    <udiDi>03401095384223</udiDi>
    <basicUdiDi>0022600LLVM-SINGLEUSEQN</basicUdiDi>
    <tradeName>Replens® Gel Applicateurs X8 FR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>03401095384223</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:47:40.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>05010724529256</udiDi>
    <basicUdiDi>0022600LLVM-MULTIUSEXB</basicUdiDi>
    <tradeName>Replens® Tube &amp; Applicator 35G UK</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Church &amp; Dwight Co., Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000020160</manufacturerSrn>
    <authorisedRepresentativeName>Sofibel</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000003191</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05010724529256</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:47:36.789Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437018976119</udiDi>
    <basicUdiDi>B-08437018976119</basicUdiDi>
    <tradeName>Papilocare Vaginal Gel</tradeName>
    <deviceName>Papilocare Vaginal Gel</deviceName>
    <manufacturerName>Procare Health Iberia SL</manufacturerName>
    <manufacturerSrn>ES-MF-000001950</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NA</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-16T19:40:31.805Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052990632312</udiDi>
    <basicUdiDi>805299063GINE003H7</basicUdiDi>
    <tradeName>NEILA Gel Vaginale</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Nirial Pharma srl</manufacturerName>
    <manufacturerSrn>IT-MF-000018760</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PZVGSM15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-16T15:27:37.874Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-060070436P</udiDi>
    <basicUdiDi>B-060070436P</basicUdiDi>
    <tradeName>Vagitab-T (10 tablets)</tradeName>
    <deviceName>Vagitab-T (10 tablets)</deviceName>
    <manufacturerName>S.I.I.T. srl</manufacturerName>
    <manufacturerSrn>IT-MF-000022188</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>WH24</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T15:18:53.633Z</lastUpdated>
  </row>
</eudamedExport>